Ocugen (OCGN) Debt Ratio (2014 - 2026)
Ocugen (OCGN) reported Debt Ratio of 0.51 for Q1 2026, up 19.52% on a YoY basis from 0.43 in Q1 2025, and down 22.46% quarter-over-quarter from 0.66 in Q4 2025.
Ocugen (OCGN) Debt Ratio (2014 - 2026) Analysis & Trends
Ocugen has reported Debt Ratio for 13 years, with the latest figure at 0.51 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 19.52% year-over-year to 0.51; the trailing twelve-month figure through Mar 2026 stood at 0.51 (up 19.52% YoY), and the FY2025 full-year result was 0.66, up 90.25% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.51, down from 0.66 in the prior quarter.
- The five-year high for Debt Ratio was 0.66 in Q4 2025, with the low at 0.01 in Q1 2022.
- Historically, Debt Ratio has averaged 0.2 across 5 years, with a median of 0.05 in 2024.
- Annual changes were most pronounced in 2022 — Debt Ratio slumped 68.32% — and 2025, when it surged 957.85%.
- Ocugen's Debt Ratio stood at 0.02 in 2022, then soared by 105.87% to 0.04 in 2023, then soared by 701.7% to 0.35 in 2024, then jumped by 90.25% to 0.66 in 2025, then retreated by 22.46% to 0.51 in 2026.
- The last three Debt Ratio figures came in at 0.51 (Q1 2026), 0.66 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.51 |
| Dec 31, 2025 | 0.66 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |